| DOXGX | HHDFX | DOXGX / HHDFX | |
| Total Expense Ratio | 0.41 | 0.85 | 48% |
| Annual Report Gross Expense Ratio | 0.46 | 0.95 | 48% |
| Fund Existence | 4 years | 14 years | - |
| Gain YTD | 1.916 | 11.207 | 17% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 119B | 1.85B | 6,446% |
| Annual Yield % from dividends | 1.34 | 1.97 | 68% |
| Returns for 1 year | 17.63 | 15.51 | 114% |
| Returns for 3 years | 137.52 | 49.39 | 278% |
| Returns for 5 years | N/A | 58.70 | - |
| Returns for 10 years | N/A | 165.99 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TMET | 32.43 | N/A | N/A |
| iShares Transition-Enabling Metals ETF | |||
| KBDU | 18.83 | -0.04 | -0.20% |
| KraneShares 2x Long BIDU Daily ETF | |||
| FFLC | 59.00 | -0.40 | -0.67% |
| Fidelity Fundamental Large Cap Core ETF | |||
| HEAL | 25.80 | -0.35 | -1.35% |
| Global X HealthTech ETF | |||
| BCHP | 35.95 | -0.76 | -2.07% |
| Principal Focused Blue Chip ETF | |||